Iqvia Holdings Inc (IQV)

$198.17 -4.83 (-2.38%)
Market Cap 33.69B
Revenue (ttm) 15.41B
Net Income (ttm) 1.37B
EPS (ttm) N/A
PE Ratio 19.50
Forward PE 18.92
Profit Margin 8.91%
Debt to Equity Ratio 2.68
Volume 1,989,600
Avg Vol 1,298,722
Day's Range N/A - N/A
Shares Out 170.00M
Stochastic %K 63%
Beta 1.32
Analysts Strong Sell
Price Target $220.45

Company Profile

IQVIA Holdings Inc. provides clinical research services, commercial insights, and healthcare intelligence to the life sciences and healthcare industries in the Americas, Europe, Africa, and the Asia-Pacific. It operates through three segments: Technology & Analytics Solutions, Research & Development Solutions, and Contract Sales & Medical Solutions. The Technology & Analytics Solutions segment offers a range of cloud-based applications and related implementation services; real world solutions th...

Industry: Diagnostics & Research
Sector: Healthcare
Phone: 919 998 2000
Address:
2400 Ellis Road, Durham, United States
MoneyGroupLLC
MoneyGroupLLC Oct. 11 at 10:17 AM
Enter: $IQV NOV 21 2025 $200 CALLS Buy in Price: $11.90 - $14.90 Take Profit: $24.73 Stop Bleeding: $13.11 ROI Potential: 66% Exit Within: 344 Minutes https://moneygroup.us/alerts
0 · Reply
SuperGreenToday
SuperGreenToday Oct. 10 at 2:57 PM
$IQV Share Price: $203.20 Contract Selected: Feb 20, 2026 $200 Calls Buy Zone: $16.32 – $20.16 Target Zone: $29.83 – $36.46 Potential Upside: 73% ROI Time to Expiration: 132 Days | Updates via https://fxcapta.com/stockinfo/
0 · Reply
MoneyGroupLLC
MoneyGroupLLC Oct. 10 at 7:20 AM
Enter: $IQV NOV 21 2025 $210 CALLS Buy in Price: $8.00 - $10.10 Take Profit: $17.76 Stop Bleeding: $7.04 ROI Potential: 122% Exit Within: 300 Minutes https://moneygroup.us/alerts
0 · Reply
nikitatrades
nikitatrades Oct. 9 at 1:40 PM
$IQV HSBC upgrades IQVIA to Buy, expecting easing regulatory clouds to support a rerating. 🔬 #IQVIA #Pharma
0 · Reply
trading__analysis
trading__analysis Oct. 9 at 1:40 PM
Analyst moves: $NVDA PT to $300 (Cantor, OW); $ORCL to $365 buy (Baird); $YUM/$MCD holds; $IQV buy upgrade;
0 · Reply
briefingcom
briefingcom Oct. 9 at 12:39 PM
$IQV: IQVIA upgraded to Buy from Hold at HSBC Securities, tgt $235 View More Stock Upgrades: https://www.briefing.com/calendars/updown?Filter=upgrades&utm_campaign=updown&utm_medium=social&utm_source=st&utm_content=link
0 · Reply
iriepett
iriepett Oct. 9 at 11:45 AM
$IQV https://fintel.io/news/evercore-isi-group-maintains-iqvia-holdings-bmv-iqv-outperform-recommendation-944
0 · Reply
MoneyGroupLLC
MoneyGroupLLC Oct. 9 at 11:35 AM
Enter: $IQV NOV 21 2025 $210 CALLS Buy in Price: $8.00 - $8.80 Take Profit: $13.12 Stop Bleeding: $7.04 ROI Potential: 64% Exit Within: 347 Minutes https://moneygroup.us/alerts
0 · Reply
jdlman
jdlman Oct. 9 at 10:52 AM
$IQV lets hope for a good day
0 · Reply
JarvisFlow
JarvisFlow Oct. 9 at 10:40 AM
HSBC updates rating for IQVIA Hldgs ( $IQV ) to Buy, target set at 195 → 235.
0 · Reply
Latest News on IQV
IQVIA to Announce Third-Quarter 2025 Results on October 28, 2025

Sep 30, 2025, 4:15 PM EDT - 11 days ago

IQVIA to Announce Third-Quarter 2025 Results on October 28, 2025

ILMN Stock vs. IQV Stock

Sep 26, 2025, 9:40 AM EDT - 15 days ago

ILMN Stock vs. IQV Stock

ILMN

IQVIA Receives WCG Pinnacle Award for Excellence in Site Relationships

Sep 16, 2025, 8:00 AM EDT - 25 days ago

IQVIA Receives WCG Pinnacle Award for Excellence in Site Relationships

IQVIA: A Positive Long-Term Outlook Despite Trump Legislation

Sep 11, 2025, 2:00 AM EDT - 4 weeks ago

IQVIA: A Positive Long-Term Outlook Despite Trump Legislation

IQVIA Announces Launch of Clinical Trial Financial Suite, a Next-Generation Platform for Integrated Financial Management

Sep 10, 2025, 8:00 AM EDT - 4 weeks ago

IQVIA Announces Launch of Clinical Trial Financial Suite, a Next-Generation Platform for Integrated Financial Management

IQVIA names Michael Fedock as financial chief

Sep 2, 2025, 9:41 AM EDT - 5 weeks ago

IQVIA names Michael Fedock as financial chief

IQVIA Announces CFO Transition in Early 2026

Sep 2, 2025, 9:00 AM EDT - 5 weeks ago

IQVIA Announces CFO Transition in Early 2026

IQVIA and Flagship Pioneering Announce Strategic Collaboration to Accelerate the Development of Breakthrough Life Sciences Companies

Aug 28, 2025, 8:00 AM EDT - 6 weeks ago

IQVIA and Flagship Pioneering Announce Strategic Collaboration to Accelerate the Development of Breakthrough Life Sciences Companies

FHTX MRNA SANA

The Big 3: BLDR, IQV, LOW

Aug 19, 2025, 12:00 PM EDT - 7 weeks ago

The Big 3: BLDR, IQV, LOW

BLDR LOW

IQVIA and Veeva Announce Long-term Clinical and Commercial Partnerships and Resolution of All Disputes

Aug 18, 2025, 9:00 AM EDT - 7 weeks ago

IQVIA and Veeva Announce Long-term Clinical and Commercial Partnerships and Resolution of All Disputes

VEEV

IQVIA: Q2 Earnings Exceeded My Expectations

Jul 22, 2025, 5:40 PM EDT - 2 months ago

IQVIA: Q2 Earnings Exceeded My Expectations

IQVIA Holdings Inc. (IQV) Q2 2025 Earnings Call Transcript

Jul 22, 2025, 2:00 PM EDT - 2 months ago

IQVIA Holdings Inc. (IQV) Q2 2025 Earnings Call Transcript

IQVIA beats quarterly estimates on resilient demand for healthcare analytics

Jul 22, 2025, 8:42 AM EDT - 2 months ago

IQVIA beats quarterly estimates on resilient demand for healthcare analytics

IQVIA Reports Second-Quarter 2025 Results

Jul 22, 2025, 7:00 AM EDT - 2 months ago

IQVIA Reports Second-Quarter 2025 Results

IQVIA: Competition Is Creating More Challenges Over The Long Haul

Jul 16, 2025, 7:54 AM EDT - 3 months ago

IQVIA: Competition Is Creating More Challenges Over The Long Haul

IQVIA to Announce Second-Quarter 2025 Results on July 22, 2025

Jul 1, 2025, 7:00 AM EDT - 3 months ago

IQVIA to Announce Second-Quarter 2025 Results on July 22, 2025

IQVIA Health Research Space Wins 2025 MedTech Breakthrough Award for ‘Best Mobile App for Patient Engagement'

Jun 16, 2025, 9:00 AM EDT - 4 months ago

IQVIA Health Research Space Wins 2025 MedTech Breakthrough Award for ‘Best Mobile App for Patient Engagement'

IQVIA Launches New AI Agents for Life Sciences and Healthcare

Jun 11, 2025, 7:00 AM EDT - 4 months ago

IQVIA Launches New AI Agents for Life Sciences and Healthcare

IQVIA Stock: Stuck In A Time Spiral - Value Play Or Bull Trap?

Jun 10, 2025, 2:23 PM EDT - 4 months ago

IQVIA Stock: Stuck In A Time Spiral - Value Play Or Bull Trap?

IQVIA Announces Pricing of Senior Notes

Jun 2, 2025, 4:37 PM EDT - 4 months ago

IQVIA Announces Pricing of Senior Notes

IQVIA Announces Offering of Senior Notes

Jun 2, 2025, 8:10 AM EDT - 4 months ago

IQVIA Announces Offering of Senior Notes

Rein Therapeutics Announces First Patient Dosed in RENEW Phase 2 Trial of LTI-03 in Patients with IPF

May 27, 2025, 7:00 AM EDT - 4 months ago

Rein Therapeutics Announces First Patient Dosed in RENEW Phase 2 Trial of LTI-03 in Patients with IPF

RNTX

IQVIA and SCRI Collaborate to Accelerate Global Oncology Trials

May 16, 2025, 8:00 AM EDT - 5 months ago

IQVIA and SCRI Collaborate to Accelerate Global Oncology Trials

IQVIA: Q1 Earnings Support Steady Optimism

May 9, 2025, 1:48 PM EDT - 5 months ago

IQVIA: Q1 Earnings Support Steady Optimism

IQVIA CFO Ron Bruehlman to speak at the Bank of America Annual Health Care Conference on May 13

May 7, 2025, 4:15 PM EDT - 5 months ago

IQVIA CFO Ron Bruehlman to speak at the Bank of America Annual Health Care Conference on May 13

IQVIA Holdings Inc. (IQV) Q1 2025 Earnings Call Transcript

May 6, 2025, 3:04 PM EDT - 5 months ago

IQVIA Holdings Inc. (IQV) Q1 2025 Earnings Call Transcript

IQVIA Reports First-Quarter 2025 Results

May 6, 2025, 7:00 AM EDT - 5 months ago

IQVIA Reports First-Quarter 2025 Results

IQVIA celebrates Marie E. Lamont and Dr. Joanne Hackett, winners of Healthcare Businesswomen's Association Awards

Apr 28, 2025, 9:00 AM EDT - 5 months ago

IQVIA celebrates Marie E. Lamont and Dr. Joanne Hackett, winners of Healthcare Businesswomen's Association Awards

IQVIA named a front-runner in generative AI innovation by global industry research and analysis firm

Apr 23, 2025, 9:00 AM EDT - 6 months ago

IQVIA named a front-runner in generative AI innovation by global industry research and analysis firm

IQVIA to Announce First-Quarter 2025 Results on May 6, 2025

Apr 21, 2025, 4:15 PM EDT - 6 months ago

IQVIA to Announce First-Quarter 2025 Results on May 6, 2025

Stabilization and improvement seen in multiple key biopharma R&D metrics, says IQVIA Institute Report

Apr 15, 2025, 8:00 AM EDT - 6 months ago

Stabilization and improvement seen in multiple key biopharma R&D metrics, says IQVIA Institute Report

IQVIA recognized as a leader in IDC MarketScape's 2024 assessment for decentralized clinical trial technologies and consulting services

Mar 10, 2025, 9:00 AM EDT - 7 months ago

IQVIA recognized as a leader in IDC MarketScape's 2024 assessment for decentralized clinical trial technologies and consulting services

IQVIA Laboratories launches Site Lab Navigator with breakthrough e-Requisition innovation to transform clinical trials

Mar 4, 2025, 9:00 AM EST - 7 months ago

IQVIA Laboratories launches Site Lab Navigator with breakthrough e-Requisition innovation to transform clinical trials

Global Healthy Living Foundation and IQVIA Institute Report Millions of Adult Vaccines Likely Missed When States Restrict Pharmacist Participation

Feb 25, 2025, 3:00 PM EST - 8 months ago

Global Healthy Living Foundation and IQVIA Institute Report Millions of Adult Vaccines Likely Missed When States Restrict Pharmacist Participation

IQVIA AI Assistant wins 2024 PM360 Innovation Award for Artificial Intelligence

Feb 24, 2025, 9:00 AM EST - 8 months ago

IQVIA AI Assistant wins 2024 PM360 Innovation Award for Artificial Intelligence

IQVIA CFO Ron Bruehlman to Speak at the TD Cowen Annual Health Care Conference on March 4, 2025

Feb 21, 2025, 9:00 AM EST - 8 months ago

IQVIA CFO Ron Bruehlman to Speak at the TD Cowen Annual Health Care Conference on March 4, 2025

IQVIA Releases 2024 Sustainability Report

Feb 20, 2025, 10:06 AM EST - 8 months ago

IQVIA Releases 2024 Sustainability Report

IQVIA: Revenues, Net Profit Margin, And A Positive Long-Term Outlook Will Pave The Way

Feb 16, 2025, 3:36 AM EST - 8 months ago

IQVIA: Revenues, Net Profit Margin, And A Positive Long-Term Outlook Will Pave The Way

IQVIA Holdings Inc. (IQV) Q4 2024 Earnings Call Transcript

Feb 6, 2025, 11:58 AM EST - 8 months ago

IQVIA Holdings Inc. (IQV) Q4 2024 Earnings Call Transcript

IQVIA Delivers Solid Q4 Growth Despite 'Choppy' Market Conditions

Feb 6, 2025, 11:37 AM EST - 8 months ago

IQVIA Delivers Solid Q4 Growth Despite 'Choppy' Market Conditions

IQVIA beats quarterly results estimates on analytics services demand

Feb 6, 2025, 8:34 AM EST - 8 months ago

IQVIA beats quarterly results estimates on analytics services demand

IQVIA Reports Fourth-Quarter and Full-Year 2024 Results; Reaffirms Full-Year 2025 Guidance

Feb 6, 2025, 7:00 AM EST - 8 months ago

IQVIA Reports Fourth-Quarter and Full-Year 2024 Results; Reaffirms Full-Year 2025 Guidance

IQVIA named to the Fortune® World's Most Admired Companies™ list, ranked No. 1 in its sector for fourth consecutive year

Feb 4, 2025, 11:00 AM EST - 8 months ago

IQVIA named to the Fortune® World's Most Admired Companies™ list, ranked No. 1 in its sector for fourth consecutive year

IQVIA to Announce Fourth-Quarter and Full-Year 2024 Results on February 6, 2025

Jan 21, 2025, 4:15 PM EST - 9 months ago

IQVIA to Announce Fourth-Quarter and Full-Year 2024 Results on February 6, 2025

IQVIA and NVIDIA Collaborate to Transform Healthcare and Life Sciences Through Advanced Agentic AI Solutions

Jan 13, 2025, 9:00 AM EST - 9 months ago

IQVIA and NVIDIA Collaborate to Transform Healthcare and Life Sciences Through Advanced Agentic AI Solutions

Digital Health Tools are Expanding in Scope and Function to Aid Patient Diagnosis, Treatment and Monitoring, Says New Report from The IQVIA Institute

Dec 23, 2024, 8:00 AM EST - 10 months ago

Digital Health Tools are Expanding in Scope and Function to Aid Patient Diagnosis, Treatment and Monitoring, Says New Report from The IQVIA Institute

IQVIA Holdings: Share Price Disconnected From Growth Outlook

Dec 12, 2024, 8:29 AM EST - 10 months ago

IQVIA Holdings: Share Price Disconnected From Growth Outlook

IQVIA CFO Ron Bruehlman to Speak at the UBS Global Healthcare Conference on November 13, 2024

Nov 6, 2024, 4:15 PM EST - 1 year ago

IQVIA CFO Ron Bruehlman to Speak at the UBS Global Healthcare Conference on November 13, 2024

IQVIA Holdings Inc. (IQV) Q3 2024 Earnings Call Transcript

Oct 31, 2024, 3:52 PM EDT - 1 year ago

IQVIA Holdings Inc. (IQV) Q3 2024 Earnings Call Transcript

IQVIA lowers annual revenue forecast amid trial delays

Oct 31, 2024, 12:50 PM EDT - 1 year ago

IQVIA lowers annual revenue forecast amid trial delays

MoneyGroupLLC
MoneyGroupLLC Oct. 11 at 10:17 AM
Enter: $IQV NOV 21 2025 $200 CALLS Buy in Price: $11.90 - $14.90 Take Profit: $24.73 Stop Bleeding: $13.11 ROI Potential: 66% Exit Within: 344 Minutes https://moneygroup.us/alerts
0 · Reply
SuperGreenToday
SuperGreenToday Oct. 10 at 2:57 PM
$IQV Share Price: $203.20 Contract Selected: Feb 20, 2026 $200 Calls Buy Zone: $16.32 – $20.16 Target Zone: $29.83 – $36.46 Potential Upside: 73% ROI Time to Expiration: 132 Days | Updates via https://fxcapta.com/stockinfo/
0 · Reply
MoneyGroupLLC
MoneyGroupLLC Oct. 10 at 7:20 AM
Enter: $IQV NOV 21 2025 $210 CALLS Buy in Price: $8.00 - $10.10 Take Profit: $17.76 Stop Bleeding: $7.04 ROI Potential: 122% Exit Within: 300 Minutes https://moneygroup.us/alerts
0 · Reply
nikitatrades
nikitatrades Oct. 9 at 1:40 PM
$IQV HSBC upgrades IQVIA to Buy, expecting easing regulatory clouds to support a rerating. 🔬 #IQVIA #Pharma
0 · Reply
trading__analysis
trading__analysis Oct. 9 at 1:40 PM
Analyst moves: $NVDA PT to $300 (Cantor, OW); $ORCL to $365 buy (Baird); $YUM/$MCD holds; $IQV buy upgrade;
0 · Reply
briefingcom
briefingcom Oct. 9 at 12:39 PM
$IQV: IQVIA upgraded to Buy from Hold at HSBC Securities, tgt $235 View More Stock Upgrades: https://www.briefing.com/calendars/updown?Filter=upgrades&utm_campaign=updown&utm_medium=social&utm_source=st&utm_content=link
0 · Reply
iriepett
iriepett Oct. 9 at 11:45 AM
$IQV https://fintel.io/news/evercore-isi-group-maintains-iqvia-holdings-bmv-iqv-outperform-recommendation-944
0 · Reply
MoneyGroupLLC
MoneyGroupLLC Oct. 9 at 11:35 AM
Enter: $IQV NOV 21 2025 $210 CALLS Buy in Price: $8.00 - $8.80 Take Profit: $13.12 Stop Bleeding: $7.04 ROI Potential: 64% Exit Within: 347 Minutes https://moneygroup.us/alerts
0 · Reply
jdlman
jdlman Oct. 9 at 10:52 AM
$IQV lets hope for a good day
0 · Reply
JarvisFlow
JarvisFlow Oct. 9 at 10:40 AM
HSBC updates rating for IQVIA Hldgs ( $IQV ) to Buy, target set at 195 → 235.
0 · Reply
SuperGreenToday
SuperGreenToday Oct. 8 at 5:54 PM
$IQV Share Price: $201.05 Contract Selected: Feb 20, 2026 $200 Calls Buy Zone: $17.00 – $21.00 Target Zone: $31.98 – $39.09 Potential Upside: 78% ROI Time to Expiration: 134 Days | Updates via https://fxcapta.com/stockinfo/
0 · Reply
MoneyGroupLLC
MoneyGroupLLC Oct. 8 at 9:24 AM
Enter: $IQV NOV 21 2025 $210 CALLS Buy in Price: $8.87 - $9.10 Take Profit: $19.07 Stop Bleeding: $7.81 ROI Potential: 115% Exit Within: 167 Minutes https://moneygroup.us/alerts
0 · Reply
MoneyGroupLLC
MoneyGroupLLC Oct. 7 at 5:53 AM
Enter: $IQV NOV 21 2025 $210 CALLS Buy in Price: $9.90 - $11.20 Take Profit: $14.65 Stop Bleeding: $8.71 ROI Potential: 48% Exit Within: 287 Minutes https://moneygroup.us/alerts
0 · Reply
MoneyGroupLLC
MoneyGroupLLC Oct. 5 at 3:47 PM
Enter: $IQV NOV 21 2025 $210 CALLS Buy in Price: $11.14 - $11.70 Take Profit: $20.05 Stop Bleeding: $9.80 ROI Potential: 80% Exit Within: 364 Minutes https://moneygroup.us/alerts
0 · Reply
SPYByte
SPYByte Oct. 5 at 8:11 AM
$IQV Contract research consistency. Steady uptrend intact. Low volatility institutional holding. Relative strength.
0 · Reply
SweepCastApp
SweepCastApp Oct. 3 at 11:32 AM
$IQV: Unusual Options Activity Alerted CALL flow observed 210x contracts at Strike price of $210 Exp on 10/17/2025 with Premium of $74K and showing BULLISH Sentiment
0 · Reply
MoneyGroupLLC
MoneyGroupLLC Oct. 3 at 6:53 AM
Enter: $IQV NOV 21 2025 $210 CALLS Buy in Price: $9.10 - $10.00 Take Profit: $21.84 Stop Bleeding: $8.01 ROI Potential: 140% Exit Within: 71 Minutes https://moneygroup.us/alerts
0 · Reply
SPYmyQQQ
SPYmyQQQ Oct. 2 at 7:23 PM
🏛️ 🚀 $IQV up ⬆️16.18% since our entry $178.50 on Sep 26, 2025 👉 FREE TRIAL! spymyqqq.com/join/ Time-stamped signals. NO B.S.!
0 · Reply
JarvisFlow
JarvisFlow Oct. 2 at 2:03 PM
Barclays has adjusted their stance on IQVIA Hldgs ( $IQV ), setting the rating to Equal-Weight with a target price of 185 → 200.
0 · Reply
MoneyGroupLLC
MoneyGroupLLC Oct. 2 at 12:53 PM
Enter: $IQV NOV 21 2025 $210 CALLS Buy in Price: $9.10 - $10.60 Take Profit: $13.92 Stop Bleeding: $8.01 ROI Potential: 53% Exit Within: 279 Minutes https://moneygroup.us/alerts
0 · Reply
SuperGreenToday
SuperGreenToday Oct. 1 at 11:59 PM
$IQV Share Price: $203.78 Contract Selected: Feb 20, 2026 $200 Calls Buy Zone: $17.68 – $21.84 Target Zone: $31.19 – $38.12 Potential Upside: 67% ROI Time to Expiration: 141 Days | Updates via https://fxcapta.com/stockinfo/
0 · Reply
MoneyGroupLLC
MoneyGroupLLC Oct. 1 at 5:51 PM
Enter: $IQV NOV 21 2025 $190 CALLS Buy in Price: $12.50 - $12.80 Take Profit: $19.25 Stop Bleeding: $11.00 ROI Potential: 54% Exit Within: 335 Minutes https://moneygroup.us/alerts
0 · Reply